Tele: 561.316.3330
Breaking Medical Device News

Wednesday, October 20, 2021

MEDICAL DEVICE NEWS MAGAZINE

A DIGITAL PUBLICATION FOR THE PRACTICING MEDICAL SPECIALIST, INDUSTRY EXECUTIVE AND INVESTOR
HomeFUNDINGProximie Raises $38m Series B Funding To Accelerate Its Expansion in U.S....

Proximie Raises $38m Series B Funding To Accelerate Its Expansion in U.S. and European Markets

Proximie is a health technology platform company focused on digitizing operating and diagnostic rooms.

Today the company announced the completion of its $38 million Series B equity financing. The round was led by F-Prime Capital, with participation from new investors Questa Capital, Eight Roads, Maverick Ventures, and the support of existing investors Global Ventures, BECO Capital, and Cedar Mundi Ventures.

The company’s mission is to save lives by sharing the world’s best clinical practices. The platform combines human expertise with the power of augmented reality (AR), machine learning (ML), artificial intelligence (AI), and advanced telecommunications.

Proximie will use the proceeds to accelerate its expansion in the U.S. and European markets. Significant investment will be directed toward commercial efforts, including new technology implementations, in addition to research and development.

The company was founded by Dr. Nadine Hachach-Haram FRCS (Plastics) – (B.E.M., British Empire Medal), in 2016. The company is building a network of operating rooms, where every interaction is captured, digitized, cataloged, and analyzed. By digitizing surgery, Proximie can accelerate the adoption of best practices and help to create better patient outcomes.

Proximie has enjoyed rapid growth over the last 12 months, having conducted over 10,000 surgical interactions in 300 hospitals in over 40 countries.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company

This infusion of capital will support the initiation of a first-in-human trial of ADAM™, the world’s first hydrogel implant designed to provide long-lasting, non-permanent contraception for men.

Adam S. Epstein New CEO of AliMed, Inc.

In his prior role as Chief Commercial Officer, Epstein directed all customer-facing, demand generation and product development activities. Under his new leadership, AliMed will continue to build a robust portfolio of contracted positions with major, national GPO’s, IDN’s, and Distribution partners to drive sales growth.

Tony Collins Appointed CFO of Xenter

“Xenter is building a platform for medical innovations that is transformational. The only way we can achieve our objectives is if we have great leaders like Tony Collins leading our company,” stated Richard J. Linder, Founder, Chairman & CEO of Xenter, Inc. “Tony brings incredible depth and experience to his new role as Chief Financial Officer.

Scott Sexton Appointed President at FIGUR8

"Scott brings to FIGUR8 30 years of workers' compensation, casualty, disability, and commercial health experience, most recently serving as a market leader for CorVel's national carrier practice sales team," said Nan-Wei Gong, CEO, and co-founder of FIGUR8.

Insulet Announces Board of Director Changes with Appointment of Luciana Borio, M.D. and Retirement of Sally W. Crawford

Luciana Borio MD is a respected physician with vast experience in advancing major regulatory and policy agendas for the United States.

Ganymed Robotics Awarded a €2.5M Grant from the EC through the EIC Accelerator Program

Ganymed Robotics is developing a radically new approach to surgical robotics by combining computer vision, a branch of artificial intelligence, and mechatronics.

By using this website you agree to accept Medical Device News Magazine Privacy Policy